雜志介紹

Esc Heart Failure雜志介紹

《Esc Heart Failure》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱ESC心力衰竭，本刊主要出版、報道醫(yī)學-CARDIAC & CARDIOVASCULAR SYSTEMS領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為3.2，最新CiteScore 指數(shù)為7。

本刊近期中國學者發(fā)表的論文主要有：

• Construction of a web-based dynamic nomogram for predicting the prognosis in acute heart failure

  Author: Gao, Rongrong; Qu, Qiang; Guo, Qixin; Sun, Jinyu; Liao, Shengen; Zhu, Qingqing; Zhu, Xu; Cheang, Iokfai; Yao, Wenming; Zhang, Haifeng; Li, Xinli; Zhou, Yanli

• Rnf144b alleviates the inflammatory responses and cardiac dysfunction in sepsis

  Author: Guo, Rennan; Wang, Jingjing; Tang, Wen; Xiao, Dong

• Prevalence and prognosis of frailty in older patients with stage B heart failure with preserved ejection fraction

  Author: Meng, Chen; Chai, Ke; Li, Ying-Ying; Luo, Yao; Wang, Hua; Yang, Jie-Fu

• MicroRNA-155-5p in serum derived-exosomes promotes ischaemia-reperfusion injury by reducing CypD ubiquitination by NEDD4

  Author: Hu, Chenkai; Liao, Junyu; Huang, Ruiyan; Su, Qiang; He, Lei

英文介紹

Esc Heart Failure雜志英文介紹

ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.